Current Membership of the Patient-Centered Outcomes Research Institute (PCORI) Governing Board
Current Membership of the Patient-Centered Outcomes Research Institute (PCORI) Governing Board
Following are brief biographies of the current members of the PCORI Board of Governors.
Debra Barksdale, PhD, RN, is Professor and Associate Dean of Academic Programs at the Virginia Commonwealth University in Richmond, VA. She is a researcher, certified nurse practitioner, and educator. Her research program focuses on psychological and physical stress, coping, and cardiovascular responses in African-Americans. She is a Fellow of the American Academy of Nurse Practitioners and the American Academy of Nursing. She received a BS in nursing from the University of Virginia, a masters in nursing from Howard University, a post-masters in teaching from the University of Pennsylvania, and a PhD in Nursing Research from the University of Michigan. Dr. Barksdale was appointed in September 2010 for a 2-year term and reappointed in September 2012 for a 6-year term.
Kerry Barnett, JD, (Vice Chair) is President and CEO of SAIF Corporation, Oregon’s not-for-profit, state-chartered workers’ compensation insurance company. He previously served as Executive Vice President of Corporate Services and Chief Legal Officer of the Regence Group, an affiliation of four not-for-profit Blue Cross/Blue Shield Plans. He also served as Oregon's state insurance commissioner and as the governor's legal counsel and senior policy advisor. He is on the Public Policy Committee and on the Strategic Communications Advisory Council of America's Health Insurance Plans. He also serves on the Legal Division Co-op Board of the Blue Cross and Blue Shield Association. He received a BA in English from the University of Rochester and a JD from Yale Law School. Mr. Barnett was appointed in September 2010 for a 2-year term and reappointed in September 2012 for a 6-year term. He was designated as Vice Chair in December 2014.
Lawrence Becker is Director of Strategic Partnerships and Alliances for Xerox Corporation in Rochester, NY, and is responsible for Global HR Vendor Optimization. He is also Chairman of the Plan Administration Committee for Xerox's ERISA plans. Since joining Xerox, he has served in several capacities in the benefits, compensation, technology, and operations arenas including as director of benefits. He previously served as vice president of human resources for Baltimore Bancorp and worked for Formica Corporation, Exxon Corporation, and American Can Company in a variety of roles. He is a member of the Executive Board of ERIC (ERISA Industry Council), a member of the Board of Directors and Finance and Audit Committee of the National Quality Forum (NQF) as well as the NQF Steering Committee on Measuring Efficiency across Patient-Focused Episodes of Care. Additionally, he was a member of the Quality Alliance Steering Committee Expansion Workgroup commissioned by the Secretary of Health and Human Services. He is a board member of the Rochester Regional Health Information Operation. He received a BS from Cornell University's Industrial and Labor Relations School. Mr. Becker was appointed in September 2010 for a 4-year term, and reappointed in 2014 for a 6-year term.
Allen Douma, MD, is Chief Executive Officer of Empower, LLC, in Ashland, OR, and a member of the AARP Board of Directors. Previously, he served as assistant director of the Oregon Department of Human Services, chief executive officer of Health Responsibility Systems, medical director for Hartford and Travelers Insurance Cos., assistant professor of CME at George Washington University, and director of Health Education for the American Medical Association. He serves on AARP's Member and Social Impact Committee and the AARP Insurance Trust. He currently serves on the Boards of the Jefferson Regional Health Alliance and PRS Affordable Housing. He was a Robert Wood Johnson Foundation clinical scholar. He received a BES (engineering science) from The Johns Hopkins University and a MD from the Medical College of Virginia. Mr. Douma was appointed in September 2010 for a 2-year term and reappointed in September 2012 for a 6-year term.
Alicia Fernandez, MD, is Professor of Clinical Medicine at the University of California, San Francisco (UCSF). In addition Dr. Fernandez is a practicing general internist in the General Medical Clinic and Medical Wards at San Francisco General Hospital. She has served on task forces on diversity, health disparities and health literacy for national organizations such as the Robert Wood Johnson Foundation, the National Quality Forum, the Agency for Healthcare Research and Quality, the American Medical Association, and the Society of General Internal Medicine. Her research has focused on health disparities, chronic disease and patient/provider communication. Dr. Fernandez received her BA from Yale University and her medical degree from Albert Einstein College of Medicine and was a Fellow at UCSF. She was appointed in February 2014 for a 6-year term.
Christine Goertz, DC, PhD, is Vice Chancellor for Research and Health Policy at Palmer College of Chiropractic and the Palmer Center for Chiropractic Research in Davenport, IA, where her research focuses on quality of outcomes for patients and the importance of provider collaboration in providing high-quality health care. Her work is focused on sub-acute and chronic lower back pain in adult populations. For over 20 years, she has addressed multidisciplinary science and health policy issues at the state and federal levels, serving as a member of the American Medical Association's Measures Implementation and Evaluation Advisory Committee, Chair of the American Chiropractic Association's Performance Measurement Task Force, and a program officer of the NIH National Center for Complementary and Alternative Medicine managing a portfolio focused on musculoskeletal disease, pain and health services research. She is a Fellow of the International College of Chiropractors. She received her doctor of chiropractic from Northwestern Health Sciences University and a PhD in Health Services Research Policy and Administration from the University of Minnesota. Dr. Goertz was appointed in September 2010 for a 6-year term and reappointed in September 2016 for a 6-year term.
Leah Hole-Marshall, JD, is Medical Administrator, Department of Labor and Industries, State of Washington, in Olympia, WA. In this role she leads the Office of the Medical Director in setting health policy and providing clinical expertise to ensure safe and effective health care is delivered to Washington's injured and ill workers. Previously she served as the Program Director for the Health Technology Assessment (HTA) program of the Washington State Health Care Authority, a program based on partnerships with public and private sector entities to ensure that medical treatments and services paid for with state health care dollars are safe and proven to work. Ms. Hole-Marshall has also led efforts to encourage patients and providers to use reliable clinical information to enhance the quality and safety of patient care. She served on the governing committee of the Medicaid Evidence-based Decisions Project at the Center for Evidence-based Policy at Oregon Health and Science University. She received a BA from Evergreen State College and a JD from Seattle University. Ms. Hole-Marshall was appointed in September 2010 for a 2-year term and reappointed in September 2012 for a 6-year term.
Russell Howerton, MD, is Chief Medical Officer and Vice President for Clinical Operations at Wake Forest Baptist Medical Center in North Carolina. He is responsible for leading the quality, safety, and risk functions for the system’s four hospitals and for its ambulatory clinics and physicians’ organizations. These responsibilities include oversight of the quality of care and moving from “volume to value” in clinical services in collaboration with the clinical chairs, chief nurse executives and other management partners. His VP Clinical Operations role includes responsibility for several service lines, the ambulatory dialysis network, rehabilitation services and an employed physician network. Dr. Howerton’s key areas of interest include the operational and clinical aspects of care for patients with complex chronic conditions and co-morbidities and improving the experience of patients with those conditions. Dr. Howerton has served as the chair of the Chief Medical Officers Group of the Association of American Medical Colleges. He received his medical degree from Vanderbilt University School of Medicine. He was appointed in September 2016 for a 6-year term.
Gail Gibson Hunt is President and CEO of the National Alliance for Caregiving, located in Bethesda, MD. The Alliance is a diverse coalition of national organizations that seeks to advocate for and serve as a research and training resource for family caregivers of patients/consumers across the lifespan. Ms. Hunt's previous positions include President of a management consulting firm specializing in aging and a senior manager for Human Services at KPMG Peat Marwick. Ms. Hunt serves as a member of the Advisory Panel for Medicare Education, and as a board member of the Center for Advancing Health of Vinson Hall in McLean, VA, and was on the NIH State of the Science Panel on Preventing Alzheimer's and Cognitive Decline. She was a member of the Policy Committee of the 2005 White House Conference on Aging. She has been active in many national and international conferences on family caregiving, as well as helping to develop an international coalition of caregiving groups. Ms. Hunt received her BA from Columbia University. Ms. Hunt was appointed on November 12, 2010 to replace Andrew Imparato who resigned from the board to take a position as Senior Counsel and Disability Policy Director for the Senate Health, Education, Labor & Pensions (HELP) Committee. Her first term ended in 2014, and she was reappointed in 2014 for a 6-year term.
Harlan Krumholz, MD, SM, is the Harold H. Hines, Jr. Professor of Medicine and Epidemiology and Public Health at Yale University School of Medicine in New Haven, CT, and is a practicing cardiologist. He serves as Director of the Yale-New Haven Hospital Center for Outcomes Research and Evaluation (CORE) and as Director of the Robert Wood Johnson Clinical Scholars Program at Yale. His work in outcomes research focuses on determining optimal clinical strategies and improving the prevention, diagnosis and treatment of cardiovascular disease. He serves on the Board of Trustees of the American College of Cardiology and on the Board of Directors of the American Board of Internal Medicine and is a member of the Association of American Physicians, the American Society for Clinical Investigation, and the Institute of Medicine. He received a BS from Yale, a masters in Health Policy and Management from the Harvard University School of Public Health and a MD from Harvard Medical School. Dr. Krumholz was appointed in September 2010 for a 2-year term and reappointed in September 2012 for a 6-year term.
Richard E. Kuntz, MD, MSc, is Senior Vice President and Chief Scientific, Clinical, and Regulatory Officer of Medtronic, Inc. in Minneapolis, MN. Prior to joining Medtronic, he was the founder and Chief Scientific Officer of the Harvard Clinical Research Institute, a university-based contract research organization which coordinates National Institutes of Health and industry clinical trials with the Food and Drug Administration. His major interests are traditional and alternative clinical trial design and biostatistics. He also served as Associate Professor of Medicine at Harvard Medical School, Chief of the Division of Clinical Biometrics, and an interventional cardiologist in the division of cardiovascular diseases at the Brigham and Women's Hospital in Boston, MA. He received a BA from Miami University, a masters in biostatistics from the Harvard University School of Public Health and a MD from Case Western Reserve University School of Medicine. Dr. Kuntz was appointed in September 2010 for a 2-year term and reappointed in September 2012 for a 6-year term.
Sharon Levine, MD, is Associate Executive Director for The Permanente Medical Group of Northern California; a large multi-specialty group practice in Oakland, CA within Kaiser Permanente's integrated delivery system. A board-certified pediatrician, she has held multiple leadership roles with this group practice including Chief of Pediatrics. She held academic appointments at both Tufts University and Georgetown University Schools of Medicine and spent two years as a clinical associate researching infant nutrition at the National Institutes of Health's Institute of Child Health and Human Development. She is a board member of the Reagan-Udall Foundation, Integrated Healthcare Association, and the Public Health Institute of California, and member of the California Medical Board. She is an adjunct associate for the Center for Health Policy/Center for Primary Care and Outcomes Research at Stanford University. She received a BA from Radcliffe College at Harvard University and a MD from Tufts University School of Medicine. Dr. Levine was appointed in September 2010 for a 6-year term and reappointed in September 2016 for a 6-year term.
Freda Lewis-Hall, MD, is Senior Vice President and Chief Medical Officer for Pfizer Inc., in New York City, NY, where she leads the Pfizer Medical division, responsible for ensuring the safe and effective use of Pfizer medicines, including regulatory and safety strategy and operations, medical information and medical affairs, and quality assurance. She was formerly Chief Medical Officer and Executive Vice President of Medicines Development at Vertex Pharmaceuticals, Inc., a Senior Vice President of Medical Affairs at Bristol-Myers Squibb, Vice President of Research and Development at Pharmacia Corp., and product team leader at Eli Lilly and Co., where she founded the Lilly Center for Women's Health. Dr. Lewis-Hall served previously as a special advisor to the National Institutes of Mental Health, focusing on outreach and patient education for minority Americans. She was formerly Vice Chair of the Department of Psychiatry at Howard University College of Medicine and member of the American Psychiatric Association Foundation Board. She currently is a Fellow of the New York Academy of Medicine, and serves on the boards of the Foundation of the National Institutes of Health and the Society for the Advancement of Women's Health Research. She received a BA from The Johns Hopkins University and a MD from Howard University College of Medicine. Dr. Lewis-Hall was appointed in September 2010 for a 4-year term and reappointed in 2014 for a 6-year term.
Barbara J. McNeil, MD, PhD, is the Ridley Watts Professor and founding head of the Department of Health Care Policy at Harvard Medical School and a professor in the Department of Radiology at Harvard Medical School and at Brigham and Women’s Hospital in Boston, Massachusetts. Her research has focused on technology assessment and quality of care. She has done work in these areas in both the private and public sectors, including in the Veterans Health Administration. Recent publications and research address racial disparities in cancer care, the effect of tumor boards on the quality of cancer care, and area-level variations in cancer care outcomes. She is a member of the Institute of Medicine of the National Academy of Sciences and has served as chair of its Board of Health Care Services. She is currently vice chair of the Nuclear and Radiation Studies Board of the National Academy of Sciences. She previously served as a member of the Prospective Payment Assessment Commission (a precursor to MedPAC) and on the Publications Committee of the New England journal of Medicine. Dr. McNeil received her MD from Harvard Medical School and her PhD from Harvard University. She was appointed in September 2014 for a 6-year term.
Grayson Norquist, MD, MSPH, (Chair) is Vice-Chair, Emory University Department of Psychiatry and Behavioral Sciences, and Chief of the Psychiatry Service at Grady Health System. He is a member of the Board of Directors for the American Psychiatric Association Foundation and the American Psychiatric Association. He served in a number of leadership positions at the National Institute of Mental Health (NIMH), including Director of the Division of Services and Intervention Research, a division responsible for funding clinical, prevention, and services research at NIMH. He is on the editorial board of Psychiatric Services, served on the editorial board of the Archives of General Psychiatry and the Journal of Mental Health Policy and Economics, and has received various national government and public awards, including the NIH Director’s Award, the NIH Special Service Award, and the National Alliance on Mental Illness Exemplary Psychiatrist Award. He received a BA from the University of Mississippi, an MD from UMMC and a master of science in public health from the UCLA School of Public Health. He completed his training in psychiatry at UCLA where he was also a Robert Wood Johnson Clinical Scholar. His research and community work focuses on improving the quality of mental health services provided to underserved populations. Dr. Norquist was appointed in September 2010 for a 4-year term, and reappointed in 2014 for a 6-year term. He was re-designated as Chair in September 2016 for a second 3-year term.
Ellen Sigal, PhD, is Chairperson and founder of Friends of Cancer Research, a cancer research think tank and advocacy organization in Washington, DC. During the last twenty years, she has been an advocate for finding new and better treatments for patients through advancing science and research. She has served on the National Cancer Institute Board of Scientific Advisors and the National Institutes of Health Director's Council of Public Representatives. She was a presidential appointee to the National Cancer Advisory Board where she chaired the Budget and Planning Committee that oversees the federal cancer budget. She is currently Vice-chair of the Board of Directors of the Reagan-Udall Foundation for the FDA and Chair of the Public-private Partnerships Committee of the Foundation for the National Institutes of Health. She is a board member of the American Association of Cancer Research Foundation and Duke University Cancer Center. She received a BA and masters from Brooklyn College and a PhD from Rutgers. Dr. Sigal was appointed in September 2010 for a 6-year term and reappointed in 2016 for a 6-year term.
Kathleen Troeger, MPH, is Director of Outcomes Research for Hologic, Inc. in Massachusetts. At Hologic—a global healthcare and diagnostics company—Ms.Troeger provides strategic direction for health outcomes and comparative research and clinical studies to demonstrate the value of diagnostic and surgical products to patients, providers and policy makers. Her areas of focus include in vitro diagnostics, molecular diagnostics, cytopathology, preventive and diagnostic imaging, endocrinology and reproductive health. She has served on several working groups of the Advanced Medical Technology Association, including the Diagnostic Value Framework Task Force. Ms. Troeger previously held positions at Organon Pharmaceuticals and Pfizer/Parke-Davis Women’s Health Care. A graduate of Vassar College, she received her Master of Public Health from the University of Massachusetts. She was appointed in September 2016 for a 6-year term.
Robert Zwolak, MD, PhD, is a vascular surgeon at Dartmouth-Hitchcock Medical Center in Lebanon, NH and professor of surgery at the Dartmouth Medical School. He is also Chief of Surgery at the White River Junction Veterans Administration Medical Center in White River Junction, VT, and director of the Non-invasive Vascular Laboratory. He has a special interest in health care policy issues as they relate to vascular surgery and has been instrumental in working with the Society for Vascular Surgery to create a data registry and form a comparative effectiveness committee. Currently serving as President of the Society for Vascular Surgery, he has held other positions of leadership including governor of the American College of Surgeons, president of the New England Society for Vascular Surgery, and member of the Society for Vascular Surgery Board of Directors. He served on the AMA/Specialty Society Relative Value Update Committee. He received a BS from Rensselaer Polytechnic Institute, a PhD in molecular biology and pathology and a MD from Albany Medical College. Dr. Zwolak was appointed in September 2010 for a 6-year term and reappointed in 2016 for a 6-year term.